Sarcopenia in the ICU - Key Recent Articles

1. Meta-Analyses & Systematic Reviews (Highest Evidence)

• 25 studies, 12,347 patients
• Sarcopenic ICU patients had 2.28x higher odds of mortality (95% CI: 1.83-2.83)
• In COVID-19 patients, low skeletal muscle mass raised in-hospital mortality OR to 5.84
• CT muscle measurements correlated inversely with CRP (r = -0.315), fibrinogen (r = -0.392), and D-dimers
• Combined CT-sarcopenia + inflammatory marker models outperformed APACHE II, SOFA, CURB-65, and PSI scoring systems

• Highlights the 2023 EWGSOP2 update emphasizing muscle strength over mass as the primary sarcopenia criterion - this is challenging to assess in sedated/intubated ICU patients
• Clinical Frailty Scale (CFS) remains the most used frailty tool in ICU
• Frailty worsens by hospital discharge but improves by 6 months post-ICU
• Multidimensional interventions (patient-tailored mobilization + nutrition) are most promising
• No unified sarcopenia definition exists for the ICU setting - a major research gap

• 8 prospective cohort studies, 411 critically ill children
• Pooled mean muscle mass loss of 8.9% in the first 5-7 days of PICU admission
• Using >10% loss as the threshold, 49.2% of children developed muscular atrophy
• Highlights that muscle wasting in critical illness is not confined to adults

2. Reviews (Narrative / Scoping)

• Covers the full arc from ICU to post-ICU: pre-existing sarcopenia/obesity, ICU complications, and recovery phase
• Key mechanisms identified: mitochondrial dysfunction, autophagy dysregulation, epigenetic modifications, cellular senescence, immune cell dysfunction, stem cell exhaustion, extracellular matrix remodeling
• Emphasizes that pathophysiology is dynamic - mechanisms differ between acute ICU phase and post-ICU recovery
• Proposes multi-approach treatments integrating nutritional, physical, and biological interventions

• Covers pathophysiology: systemic inflammation, immobilization, catabolic stress, mitochondrial dysfunction, immune dysregulation
• Discusses diagnosis: CT (gold standard), ultrasound, biomarkers, functional testing
• Emerging therapies: AI-based automated screening, NMES, targeted pharmacologic agents
• Highlights that ICU-acquired sarcopenia and myosteatosis remain under-recognized in routine practice

• Describes the "geriatric ICU phenotype": frailty, comorbidity, cognitive decline, malnutrition, sarcopenia, loss of autonomy, immunosenescence, and inflamm-aging acting together
• Sarcopenia contributes to worse short- and long-term prognosis beyond acute illness severity
• Argues for comprehensive geriatric assessment alongside standard ICU severity scores

• Reviews CT-measured psoas muscle area/density as a predictor of major adverse cardiac events and mortality in critically ill patients
• Positions psoas measurements as accessible, reproducible biomarkers from routine imaging

3. Randomized Controlled Trial

• Combined neuromuscular electrical stimulation (NMES) + high protein supplementation (mean 1.3 g/kg/day) + physical therapy vs. standard ICU care
• NMES+HPRO+PT group: less lower extremity muscle volume loss, larger thigh cross-sectional area, positive nitrogen balance on days 5/9/14, and significantly less delirium
• No difference in ICU LOS or mechanical ventilation days
• Supports combined intervention strategy for mitigating sarcopenia in mechanically ventilated patients

4. Observational/Diagnostic Studies

• Ultrasound-measured quadriceps thickness (rectus femoris + vastus intermedius) at 48h post-admission
• RF thickness negatively correlated with Charlson comorbidity index, NUTRIC score, NRS2002, and frailty index
• Confirms bedside ultrasound as a practical, useful tool for monitoring sarcopenia, nutritional status, and functional outcomes

• Measured rectus femoris and vastus intermedius thickness on day 3 and day 10 of ICU admission
• Rectus femoris lost ~2.9 cm, vastus intermedius ~2.6 cm over 7 days (statistically significant)
• Strain elastography ratio showed a trend toward increased muscle stiffness but did not reach significance
• Ultrasound confirmed as a practical, accessible bedside tool; elastography needs further study

• Low baseline muscle mass and poor skeletal muscle quality both associated with mortality in critically ill children

Key Takeaways from the Literature